Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Digital Health & Informatics
Diversity, Equity and Inclusion
Health & Wellness
Opioids & Pain Management
Sterile Compounding
Favorite
Like
Facebook
Tweet
Print
Kendall Johnson
Poster(s):
(2-359) Evaluation of the rate of euglycemic ketoacidosis as a significant adverse event associated with the usage of continuous renal replacement therapy
Monday, December 9, 2024
10:45 AM – 11:45 AM